Loading...
High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
We report a novel group of clinically aggressive spinal cord ependymomas characterized by Grade III histology, MYCN amplification, an absence of NF2 alterations or other recurrent pathogenic mutations, and a unique methylation classifier profile. Seven cases were found to have MYCN amplification in...
Na minha lista:
| Udgivet i: | Acta Neuropathol Commun |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7346356/ https://ncbi.nlm.nih.gov/pubmed/32641156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-020-00973-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|